2003
DOI: 10.1128/aem.69.10.5983-5991.2003
|View full text |Cite
|
Sign up to set email alerts
|

Identification and Characterization of the CYP52 Family of Candida tropicalis ATCC 20336, Important for the Conversion of Fatty Acids and Alkanes to α,ω-Dicarboxylic Acids

Abstract: Candida tropicalis ATCC 20336 excretes ␣,-dicarboxylic acids as a by-product when cultured on n-alkanes or fatty acids as the carbon source. Previously, a ␤-oxidation-blocked derivative of ATCC 20336 was constructed which showed a dramatic increase in the production of dicarboxylic acids. This paper describes the next steps in strain improvement, which were directed toward the isolation and characterization of genes encoding the -hydroxylase enzymes catalyzing the first step in the -oxidation pathway. Cytochro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
89
0
1

Year Published

2005
2005
2022
2022

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 133 publications
(96 citation statements)
references
References 20 publications
(20 reference statements)
0
89
0
1
Order By: Relevance
“…CYP52 enzymes have been found in soil yeasts such as Candida tropicalis and Candida maltosa. These P450 enzymes are commonly responsible for the first and rate-limiting step in the ω-oxidation of n-alkanes and/or fatty acids [10][11][12][13]. The CYP52 from C. albicans was previously identified and was shown in vivo to possibly play a role in multidrug resistance, although it was not involved in azole drug resistance [14].…”
Section: Introductionmentioning
confidence: 99%
“…CYP52 enzymes have been found in soil yeasts such as Candida tropicalis and Candida maltosa. These P450 enzymes are commonly responsible for the first and rate-limiting step in the ω-oxidation of n-alkanes and/or fatty acids [10][11][12][13]. The CYP52 from C. albicans was previously identified and was shown in vivo to possibly play a role in multidrug resistance, although it was not involved in azole drug resistance [14].…”
Section: Introductionmentioning
confidence: 99%
“…They contain enzyme systems like the diiron-and copper-containing methane monooxygenases found in many methanotrophs, such as Methylococcus capsulatus (Bath) (24), integral membrane-bound diiron AlkB proteins present in many ␣, ␤, and ␥-proteobacteria and high-GϩC-content gram-positive bacteria (40), and membranebound heme-containing cytochrome P450 enzymes (CYP) found in many alkane-degrading yeasts and fungi (3,9,36).…”
mentioning
confidence: 99%
“…A whole cell biocatalyst is a cheaper option than the isolated or immobilized enzyme [106]. The pathogenic yeast, C. tropicalis, has been commonly engineered for whole cell biotransformation of aliphatic feedstock to LCDCAs [14,25]. However, Y. lipolytica has safe status, and has been categorized as a GRAS microorganism by the FDA (Food and Drug Administration) [56,88].…”
Section: Discussionmentioning
confidence: 99%
“…Despite some chemical based-production of LCDCA at large scale, the high price of the LCDCAs, and their limited commercial availability are still major constraints in expanding the spectrum of their application [25]. Therefore, researchers should use various renewable resources for the sustainable production of these multi-purpose building blocks.…”
Section: Discussionmentioning
confidence: 99%